Switch to:
More From Other Websites
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support... Sep 22 2014
Pfizer Foundation Provides $2 Million In Grants To Support ‘Last-Mile’ Vaccine Coverage In... Sep 19 2014
Merck Enters into Licensing Agreement with Sun Pharma Sep 18 2014
FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
FDA OKs faster-acting label for ED drug Stendra Sep 18 2014
French cancer immunotherapy specialist OSE Pharma prepares IPO Sep 18 2014
French cancer immunotherapy specialist OSE Pharma prepares IPO Sep 18 2014
Bayer to float plastics business and focus on life sciences Sep 18 2014
Isis Pharmaceuticals CEO: Not changing name, terrorists c... Sep 17 2014
Alzheimer's drug fight Sep 16 2014
These Two Companies Could Be Pfizer's Top Targets Sep 15 2014
Takeover Panel proposes tougher rules for deal promises Sep 15 2014
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor Sep 12 2014
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor Sep 12 2014
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor Sep 12 2014
Pfizer CEO is Still Weighing Inversion Deals Sep 12 2014
Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies Sep 12 2014
Pfizer says 'window still open' for tax inversions Sep 11 2014
7 Pictures Are Worth 20 Prudent Speculator Stock Picks Sep 11 2014
Pfizer Inc. Trying To Claw Its Way Back Up After Pullback Sep 10 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 3 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK